SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-005633
Filing Date
2024-01-10
Accepted
2024-01-10 08:01:34
Documents
14
Period of Report
2024-01-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d435653d8k.htm   iXBRL 8-K 30616
2 EX-3.1 d435653dex31.htm EX-3.1 6594
  Complete submission text file 0001193125-24-005633.txt   208572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eftr-20240109.xsd EX-101.SCH 4334
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20240109_def.xml EX-101.DEF 14500
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20240109_lab.xml EX-101.LAB 24328
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20240109_pre.xml EX-101.PRE 15598
8 EXTRACTED XBRL INSTANCE DOCUMENT d435653d8k_htm.xml XML 5792
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 24524891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)